Inflammatory

RSS

CYP11A1 expression identifies anaphylaxis risk in children with peanut allergy

March 5, 2018

Bristol-Myers Squibb presents phase Ib data for anti-PD-L1 BMS-936559 in sepsis

March 1, 2018

Accro Bioscience divulges necrosis inhibitors

Feb. 16, 2018

Galecto Biotech discovers galectin inhibitors

Feb. 1, 2018

Blade Therapeutics identifies new calpain inhibitors

Jan. 29, 2018

BI-2545 shows promise for the unmet medical need in IPF treatment

Jan. 12, 2018

DS-28120313 shows in vivo efficacy as a potent orally active hepcidin production inhibitor

Dec. 13, 2017

Cardiac Hsl gene knockdown provides model of hypoxia tolerance

Dec. 1, 2017

Bristol-Myers Squibb initiates phase I trial of BMS-986235 in healthy subjects

Nov. 24, 2017

Spingotec Therapeutics divulges DPP3 inhibitors

Nov. 22, 2017